Related Experiment Videos
Juvenile spondyloarthropathies.
1Division of Rheumatology and Pediatric Rheumatology, Saint Louis University Health Sciences Center, MO 63104, USA.
Current Opinion in Rheumatology
|July 26, 2000
Summary
This review highlights juvenile spondyloarthropathies, noting MR imaging for sacroiliitis detection and anti-inflammatory cytokines in milder cases. Sulfasalazine is safe and effective, but physical fitness may decline in older patients.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Medical Imaging
Background:
- Juvenile spondyloarthropathies (JSA) represent a significant group of chronic pediatric rheumatic diseases.
- Understanding their clinical spectrum, diagnostic tools, and therapeutic options is crucial for effective management.
Purpose of the Study:
- To review recent literature on juvenile spondyloarthropathies.
- To synthesize findings on clinical characteristics, diagnostic advancements, immunologic aspects, genetic associations, therapeutic interventions, and long-term outcomes.
Main Methods:
- Literature review of recent studies on juvenile spondyloarthropathies.
- Analysis of case reports, imaging studies, cytokine investigations, genetic association studies, and therapeutic trials.
Main Results:
- Magnetic resonance (MR) imaging aids in detecting sacroiliitis in children.
- Anti-inflammatory cytokines may correlate with milder disease presentations.
- Sulfasalazine demonstrates safety and efficacy in treating chronic arthritis, including JSA.
- Genetic polymorphism is associated with acute anterior uveitis in patients with JSA.
- Reduced aerobic fitness is observed in patients with JSA in remission.
Conclusions:
- Recent literature provides valuable insights into the multifaceted nature of juvenile spondyloarthropathies.
- Advancements in imaging and understanding of immunologic factors are improving diagnosis and management.
- Therapeutic options like sulfasalazine are effective, but long-term monitoring for physical fitness is recommended.